This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

AstraZeneca aims to confront UK plausibility standard at Supreme Court

By Douglas Clarke-Williams ( July 25, 2025, 16:14 GMT | Insight) -- AstraZeneca has called for the UK Supreme Court to hear its appeal against a recent Court of Appeal decision concerning a generic version of diabetes medication. The pharmaceutical giant intends to argue that the UK’s approach to assessing plausibility has become too stringent and needs to realign itself with the European stance.Following an adverse decision by the UK Court of Appeal which saw AstraZeneca’s patent for diabetes drug Forxiga declared invalid (see here), the company has now submitted directly to the Supreme Court to have its appeal heard....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections